Anatara Lifesciences Ltd (ASX:ANR) Quarterly Cashflow
Anatara Lifesciences Ltd (ASX:ANR) is pleased to release its Appendix 4C for the quarter ending 31st December 2019. The Company's cash plus term deposits at the end of the quarter stood at $4.30m
Companies in the News
Health & Pharm General
Regeneus Ltd (ASX:RGS) AGC Agreement Termination Paves Way for Commercial Partner
Regeneus Ltd (ASX:RGS), a clinical-stage regenerative medicine company, has come to a mutual agreement with Japan-based manufacturer AGC Inc to terminate their exclusive manufacturing licence and joint venture agreement.
Anatara Lifesciences Ltd (ASX:ANR) Finalises Draft Protocol for IBS Clinical Trial
Anatara Lifesciences (ASX:ANR) is pleased to provide an update on the protocol for its clinical trial in irritable bowel syndrome (IBS) for its GaRP dietary supplement.
Anatara Lifesciences Ltd (ASX:ANR) Achieves Preclinical Milestone
Anatara Lifesciences (ASX:ANR) is pleased to provide an update on its GaRP dietary supplement preclinical milestones, which is being developed to specifically target two human gastrointestinal disorders, inflammatory bowel disease (IBD) and irritable bowel syndrome (IBS).
Cann Global Limited (ASX:CGB) Strategic Landmark Cannabis Opportunity in South Africa
The Board of Cann Global Limited (ASX:CGB) is pleased to announce that it has entered into a Heads of Agreement with the South African company Koegas Medicinal Herbs (Pty) Ltd to establish a Joint Venture (CGB to hold 70%) in medicinal Cannabis production and distribution in Africa.
Regeneus Ltd (ASX:RGS) Receives Innovation Grant
Regeneus Ltd (ASX:RGS), a clinical-stage regenerative medicine company, has received $50K in funding as part of the Innovation Connections Grant from the Australian Government's Department of Industry, Innovation and Science.
PSR Life Sciences Conference 28 November 2019: Anatara Life Sciences (ASX:ANR), Steve Lydeamore (CEO)
Anatara Lifesciences Ltd (ASX:ANR) CEO Steve Lydeamore presented to investors at the Pitt Street Research Life Sciences Conference in Sydney last month. During his presentation, Steve spoke to the Anatara story and the exciting year we have ahead with upcoming corporate milestones on both our human and animal health product opportunities.
Health & Pharm General Next Page▸
Banking & Finance
- Ellis Martin Report: EMX Royalty Corp's David Cole Discusses Nevada, Turkey and Serbia Projects amid Recent Transactions
- Martin Place Securities Commissioned Research Report - Nova Minerals Ltd (ASX:NVA)
- Ellis Martin Report: US Global Investors' Frank Holmes on Blockchain, Crypto Currency, Bitcoin and Yes Virginia, Gold!
Oil Gas & Energy
- State Gas Limited (ASX:GAS) Update Production Testing and Reserve Certification
- Deep Yellow Limited (ASX:DYL) Nova JV Drilling for 2019 Completed on EPL3670
- EON NRG Ltd (ASX:E2E) Well Completion Update
Social Media
